Last edition
News about "Mahima Datla"
Biodeal Acquires Biological E Facility for Sterile Injectables
Biodeal Pharmaceuticals acquires a Biological E facility, adding 135 million-unit annual capacity, with its Carbapenem line now operational and validated.
Mahima Datla | 30/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members